gamesinvestor
09 Mar 2017
Re: Massively overpriced? pics -- it looks like this guy doesn't agree with me, he's just loaded up a these prices :-[link] then again he's invested in banks and Vodafone, so good luck with that. I shall pass any upside in banking shares in the knowledge that I won't need to wake up one morning to find a queue outside the place and no one can get their cash out.Games - what's happening to Deutsche Bank should be adequate warning I would have thought.
picstloup
28 Feb 2017
Re: Massively overpriced? Everything Games wrote in November is still true (well fy profits were flat rather than continuing to decline) with Q4 revenues badly down, but the share price is close to all time highs.The only explanation that I can think of is the possibility of a takeover. I'm happy with the 130% rise (+ divis) my modest punt 6 years ago has made, but certainly wouldn't be buying now.
gamesinvestor
14 Nov 2016
Massively overpriced? I guess the recent fall in the share price has been down to the lack of a buyer stepping up to the plate.Even apart from that, isn't this stock optimistically priced at best?Profits have declined every year for the last 5 (£862M down to £628M)A fall of over 27%It's achieved this with a small rise in revenue from £4,270M to £4,634 --- a rise of 8.5%So is this competitive price pressure?The scary part during this 5 year period is the borrowings.This has jumped from £16M in 2011 to £1,434M (£1.4Billion) - a rise of massive proportionsWhat looks even more alarming is the cash flow -- which has just about hit the crxpper.operating cash flow £842M in 2011 -- in 2015 it's negative at (£429M).Yes S&N make wonderful products and they appeal to an ageing population, but the business looks sick.The stocks worth about 500p. Unless others have another method of justifying why it's still at twice that price?Games
LK Hyman
13 Oct 2016
Re: Ugly ITDYA,I think the price of this puppy is often influenced by the perception of the probability that someone like J&J, Stryyker or Zimmer (please, let it not be Zimmer!) may mount a takeover bid. Perhaps the probability has recently been deemed low I dunno and that is why the share price has been disappointing.I've got 5.6% of my wad here so am keen to see some action!LKH on the flybridge demand for new hips, knees and giant elastoplast can only go up, surely?
In the dark yet again
12 Oct 2016
Ugly S&N very much an international business; vast majority of income non-GBP so you would have thought it should be flying but take the huge $/£ move out of the equation and it looks pretty ugly since the Brexit vote.You might have to tweak the link to the 6 months option but the ADR $34.65 prior to the vote, $30.66 now. Given where S&N does most of it's business it's a much better reflection of the SP performance than the GBP historicals.[link] seen any real news, not for months, so not sure why as I would have though S&N would be significant beneficiaries of weak Sterling. I must be missing something. Anyone any ideas why the 10%+ fall since the vote... or is it just a feeling that this is going ex-growth so being re-rated down?Regards,ITDYA, not in huge, 2000 odd shares but enough to be concerned.
Yee Wo
07 Oct 2016
Re: Another Disgrace " I would LOVE to be able to buy some of this business at lower levels than today........"My comment - 19 May 16.Well Yesterday I finally bought some Smith & Nephew at 1223p. S&N is now 3% of my portfolio. I do like the high ROCE in this business! GLA fellow Shareholders!!
walrusty
22 Sep 2016
Much better today OK guys,you win.Today's price makes me feel much better,and will probably annoy all those holders who have sold out to make up the 300,000 a day buy-back requirement.Good news from the Florence gathering.
LK Hyman
27 Aug 2016
Re: Buy back Norman,I tend to agree with you. Many companies which do buy backs tend to do 'em at exackly the wrong time, ie when the share price is high rather than low. However, since SN's share price has generally been going up pretty smartly over the last three years or so, their average buy back price will be much lower than the current share price and can therefore be reckoned " a success".I haven't actually checked how many they bought back when (and what the share price was on each occasion) so if anyone would like to undertake this mind-numbingly boring task, he or she would earn the undying gratitude ofLKH on the flybridge
Norman Barrington
26 Aug 2016
Re: Buy back Surely Walrusty if they return capital to the owners of this company by way of a Special Dividend, The SP would fall by that exact amount on the day it goes XD?Buying back shares, (artificially) enhances earnings ratios and increases the dividend by distributing it to fewer shares in shareholders hands?See the chart below? I topped up a bit on lows but otherwise held steady over these three years, and I for one wouldn't grumble. Also nice to hold a company that make products that are life changing for the better for it's end customers. One for those concerned about ethical holdings.
walrusty
26 Aug 2016
Buy back So since hitting £13/share the buy-back of usually 200000 a day seems to have done absolutely nothing for the share price,and management are wasting shareholders capital doing this.Please stop this at once and return capital to the owners of this company by way of a Special Dividend.
walrusty
16 Aug 2016
£13 per share!! This is amazing(yesterdays close).Why would it stop there?
gamesinvestor
11 Jul 2016
Burberry ""Ms Fairweather will be replaced by Julie Brown, who will become chief operating and financial officer. Ms Brown joins from Smith & Nephew, the orthotics maker, where she is currently chief financial officer. ""Games
Ripley94
09 Jul 2016
Re: It's a goddamn disgrace! Do not know if hyman gave in to temptation since April ?I took profit yesterday.
In the dark yet again
01 Jul 2016
Re: SN. CHART BREAKOUT CONFIRMED...... oldjoe1,a bit simplistic, no?"Smith & Nephew Plc is a global orthopedics company". Global indeed. The UK market is a very small part of their business, the rest worldwide. Not saying it's all USD based but a big chunk will be in $s or currencies on which the $ is a major influence.So, Sterling collapsing 10% against the $ immediately means S&Ns revenue, profits etc increase 10% in £ terms on the spot. Costs are more UK/GBP related and it will take time for the inevitable increased costs (in £ terms) to feed through........ but they are inevitable; it simply costs more £s to buy the materials, energy etc etc, no way of getting away from that one.So "Broken out of a 2 year Range due to Brexit" is a true statement but solely because of Sterling's collapse. Any 'momentum' due to this would depend upon the further devaluation of £. If, as the Brexit boys have claimed, it's good for us and the world in the long run, then Sterling will recover and this move will be automatically reversed.It's a global business so $ prices, costs etc are a much better indication rather than a simple mathematical adjustment due to a major shift in exchange rates. Have a look at the ADR price and the chart - that's a much better indication of what's happened and that shows no significant movement at all.[link] the link works, sometimes they don't)It's also true for all the other global and/or $ related shares (which are the heavy weights in the FTSE100). Given there's been a 10% fall in Sterling and the whales are all global, you could argue that, since the UK economy in relation to the world as a whole is a mere sideshow, the FTSE should have risen by (best part of?) 10% simply to the fall in GBP.Regards,ITDYA
oldjoe1
01 Jul 2016
SN. CHART BREAKOUT CONFIRMED...... SN. Smith@ NephewBroken out of a 2 year Range due to Brexit.[link] & Nephew Plc is a global orthopedics company.It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management.The company operates in two segments: Advanced Surgical Devices and Advanced Wound Management<b><u>Valuation 2016e 2017e</u></b>P/E ratio (Price / EPS) 26,7x 21,6xCapitalization / Revenue 3,16x 3,01xEV / Revenue 3,41x 3,15xEV / EBITDA 11,6x 10,2xYield (DPS / Price) 1,88% 2,07%Price to book (Price / BVPS) 3,57x 3,29x
